In the past one month, the stock price of pharmaceuticals company has gained 15 per cent, as compared to 11 per cent decline in the BSE Sensex.
Acutaas Chemicals management has revised revenue guidance upwards from 25 per cent to around 30 per cent growth for FY26.
Stocks to buy, Feb 10: JSW Steel offers strong volume growth and margin recovery potential, while Acutaas Chemicals benefits from robust CDMO-led earnings momentum, says Shrikant Chouhan of Kotak Sec